The Power of Prophetic Disclosures

Last summer, the Federal Circuit affirmed the Patent Trial and Appeal Board&rsquo;s determination that claims in a pair of patents owned by Agilent Technologies claiming chemically modified CRISPR guide RNAs are unpatentable. Agilent Techs., Inc. v. Synthego Corp. , 139 F.4th 1319 (Fed. Cir. 2025). The court agreed that an earlier published international patent application filed by Pioneer Hi‑Bred…